These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16985253)

  • 1. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).
    Lamont EB; Herndon JE; Weeks JC; Henderson IC; Earle CC; Schilsky RL; Christakis NA;
    J Natl Cancer Inst; 2006 Sep; 98(18):1335-8. PubMed ID: 16985253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.
    Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA;
    Med Care; 2008 Mar; 46(3):303-8. PubMed ID: 18388845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
    Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA
    J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of Medicare claims data for measuring use of standard multiagent chemotherapy regimens.
    Lamont EB; Lan L
    Med Care; 2014 Mar; 52(3):e15-20. PubMed ID: 22410411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Impact of CALGB 9343 on Radiation Utilization.
    Squeo G; Malpass JK; Meneveau M; Balkrishnan R; Desai RP; Lattimore C; Anderson RT; Showalter SL
    J Surg Res; 2020 Dec; 256():577-583. PubMed ID: 32805580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
    Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.
    Warren JL; Mariotto A; Melbert D; Schrag D; Doria-Rose P; Penson D; Yabroff KR
    Med Care; 2016 Aug; 54(8):e47-54. PubMed ID: 24374419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic Management.
    Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
    Clin Breast Cancer; 2015 Aug; 15(4):e197-204. PubMed ID: 25957739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
    Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
    JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm.
    Ritzwoller DP; Hassett MJ; Uno H; Cronin AM; Carroll NM; Hornbrook MC; Kushi LC
    J Natl Cancer Inst; 2018 Mar; 110(3):273-281. PubMed ID: 29873757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of smoking using Medicare data--a validation study of claims-based algorithms.
    Desai RJ; Solomon DH; Shadick N; Iannaccone C; Kim SC
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):472-5. PubMed ID: 26764576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
    Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
    Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a scientific presentation on community treatment patterns for primary breast cancer.
    Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Freeman J; Goodwin JS
    J Natl Cancer Inst; 2006 Mar; 98(6):382-8. PubMed ID: 16537830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of Medicaid claims data to identify incident cases of breast cancer in the Ohio Medicaid population.
    Koroukian SM; Cooper GS; Rimm AA
    Health Serv Res; 2003 Jun; 38(3):947-60. PubMed ID: 12822920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.
    Kroenke CH; Chubak J; Johnson L; Castillo A; Weltzien E; Caan BJ
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.